Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Gives GenomeVision $1.6M to Make Gene Sequencing Cheaper

NEW YORK, Oct. 8 - GenomeVision Service today said it has won a $1.6 million grant from the National Human Genome Research Institute to develop new technologies that can cut the cost of genome sequencing.

 

GenomeVision, the commercial-services arm of Genome Therapeutics and the only private enterprise to participate in the Human Genome Project, will use the money in this two-year grant to reduce between five- and ten-fold the sequencing cost of large-scale gene-sequencing projects.

 

Specifically, the Waltham, Mass.-based company said it will seek to reduce to nanoliters from microliters the minimum amount of DNA needed, and to develop "standard instruments" that can use microtiter plates to perform gene analysis.

 

Trimming the costs associated with gene sequencing is all the rage nowadays. A similar adventure is underway at a neighboring nonprofit facility: Craig Venter's new sequencing center plans to nurture a number of sequencing technologies, beginning with US Genomics'.

 

The Cheap Genome was even the topic of a plenary discussion at TIGR's GSAC meeting last week. The chat session, which was chaired by J. Craig, showcased a handful of companies that some say may be invited to the Venter Center.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.